Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
AstraZeneca
Boehringer Ingelheim
Mallinckrodt
Express Scripts

Last Updated: May 27, 2022

EFFIENT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Effient, and what generic alternatives are available?

Effient is a drug marketed by Daiichi Sankyo Inc and is included in one NDA.

The generic ingredient in EFFIENT is prasugrel hydrochloride. There are nineteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the prasugrel hydrochloride profile page.

Drug patent expirations by year for EFFIENT
Drug Prices for EFFIENT

See drug prices for EFFIENT

Drug Sales Revenue Trends for EFFIENT

See drug sales revenues for EFFIENT

Recent Clinical Trials for EFFIENT

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Bucheon St. Mary's HospitalPhase 4
Yonsei UniversityPhase 4
Gangnam Severance HospitalPhase 4

See all EFFIENT clinical trials

Paragraph IV (Patent) Challenges for EFFIENT
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
EFFIENT Tablets prasugrel hydrochloride 5 mg and 10 mg 022307 17 2013-07-10

US Patents and Regulatory Information for EFFIENT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Daiichi Sankyo Inc EFFIENT prasugrel hydrochloride TABLET;ORAL 022307-001 Jul 10, 2009 AB RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Daiichi Sankyo Inc EFFIENT prasugrel hydrochloride TABLET;ORAL 022307-002 Jul 10, 2009 AB RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for EFFIENT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Daiichi Sankyo Inc EFFIENT prasugrel hydrochloride TABLET;ORAL 022307-002 Jul 10, 2009 See Plans and Pricing See Plans and Pricing
Daiichi Sankyo Inc EFFIENT prasugrel hydrochloride TABLET;ORAL 022307-001 Jul 10, 2009 See Plans and Pricing See Plans and Pricing
Daiichi Sankyo Inc EFFIENT prasugrel hydrochloride TABLET;ORAL 022307-002 Jul 10, 2009 See Plans and Pricing See Plans and Pricing
Daiichi Sankyo Inc EFFIENT prasugrel hydrochloride TABLET;ORAL 022307-001 Jul 10, 2009 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for EFFIENT

See the table below for patents covering EFFIENT around the world.

Country Patent Number Title Estimated Expiration
Greece 3027650 See Plans and Pricing
South Korea 0148023 See Plans and Pricing
New Zealand 523416 Acid addition salts of hydropyridine derivatives See Plans and Pricing
Hong Kong 1011017 See Plans and Pricing
Cyprus 1110395 See Plans and Pricing
Hong Kong 1056118 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for EFFIENT

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0542411 300397 Netherlands See Plans and Pricing 300397, 20120909, EXPIRES: 20170908
0542411 C00542411/01 Switzerland See Plans and Pricing FORMER REPRESENTATIVE: BOHEST AG, CH
0542411 91589 Luxembourg See Plans and Pricing 91589, EXPIRES: 20170909
0542411 C300397 Netherlands See Plans and Pricing PRODUCT NAME: PRASUGREL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/08/503/001-014 20090225
0542411 09C0031 France See Plans and Pricing PRODUCT NAME: PRASUGREL; NAT. REGISTRATION NO/DATE: EU/1/08/503/001-014 20090225; FIRST REGISTRATION: EU/1/08/503/001/-014 20090225
0542411 CA 2009 00024 Denmark See Plans and Pricing
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Express Scripts
Boehringer Ingelheim
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.